Volume 1, Issue 1

Table of Contents Invention Highlight: NanoPacific Holdings, Inc.

Now Available:
Inventor’s Portal
Industry Sponsored Research
Dr. Kang Wang’s WIN-ing
Formula
Technology Transfer Intern-
ships for UCLA Students
Meet the Staff– Emily
Loughran
Newly Issued UCLA Patents
for 4th Quarter FY2007-2008
Open Source Software– Is
There Such a Thing as Free
Lunch?
Thinking About Using OSS?
Points to Consider
Things to Come...
Subscribe/ Contact Us
2 Chemotherapy is often looked at the death of healthy cells.
with dread and trepidation because of The nanoparticles work by re-
the numerous and well-known side ef- leasing small drug molecules when
fects. NanoPacific Holdings, Inc. is hop- needed through nanoscale gates in its
2 ing that a new invention will alleviate porous surface. Since the surface of the
the suffering of cancer patients and lead nanoparticles can be designed to iden-
to other technological tify and locate specific cells,
breakthroughs as well. Nanoparticles were when used as a cancer treat-
2
The licensed technol-
ogy from UCLA being designed to find ment, drug toxicity and other
side effects are lessened.
3 used by NanoPacific cancer cells while
Holdings is nanoparti- ignoring other cells While groundbreaking for can-
cle based. cer patients seeking relief from
within the body. harsh treatments, NanoPacific
3 The FDA has Holdings also envisions expand-
a l r e a d y a p p r o v e d t h e u s e o f ing the use of this technology outside
“chemotherapeutic agents” to treat can- the realm of medicine. Because of its
4 cer. Unlike current chemotherapy treat- simplicity, when the nanoparticle tech-
ments which attack all cells, good and nology is applied to other fields, it holds
bad, and often leave cancer patients promise for areas as diverse as food
weakened, these new nanoparticles products, cosmetics, construction and
4 were designed to find cancer cells while defense. NanoPacific’s chairman and co-
ignoring other cells within the body. chief executive officer, Joseph Boystak
Since the nanoparticles are mechanically says that, “we intend to prioritize and
4 based, once they have found cancerous aggressively pursue multiple applications
cells, they are able to release cancer in the medical, consumer, environmental
4 drugs directly to the cells, thus avoiding and industrial sectors.”

Tip of the Quarter Kathryn’s Korner

REMEMBER TO DISCLOSE
BEFORE YOU PUBLISH
Any public disclosure, such as
publishing a paper, posting results
to a public website, or presenting
findings at a conference sets the
one-year limitation for filing US
patent applications, and pre-
cludes foreign patent applica-
tions. It is advised that inventors
discuss the status of their discover-
ies with their Tech Transfer Officer
before submitting a paper or ab-
stract. To protect your idea, com-
plete an invention report form at:
www.research.ucla.edu/oip un-
der the “Faculty” link.
Welcome to the first issue of The Inventor, a quarterly newslet-
ter from the Office of Intellectual Property and Industry Spon-
sored Research. This publication is intended to provide UCLA
faculty and students with news and information about the
world of intellectual property. Whether you have a patent on
file with us, or are simply interested in the development of in-
dustry relationships within the University, you will find a
wealth of information within these short pages. UCLA strives
to be a leader in the world of intellectual property. However,
success can only come through the hard work of faculty and
their associates. We seek to highlight and educate the public and UCLA campus
on the resources that can help inventors to succeed.
Sincerely,
Kathryn Atchison, D.D.S., M.P.H.
Vice Provost, Intellectual Property and Industry Relations
Associate Vice Chancellor for Research
Volume 1, Issue 1

Now Available: Industry Sponsored Research

Inventor’s Portal
UCLA manages 1,500
active inventions, including
more than 630 U.S. and for-
eign patents. More than 400
UCLA inventions have been
licensed to companies.
The Inventor Portal
was developed to allow faculty
to go to a secure website 24/7
to review the status of their
inventions. This includes infor-
mation on where an invention
stands in the patent applica-
tion process, the licensing
status, and who manages the
invention.
Faculty inventors can
logon to the Portal at http://
inventor.research.ucla.edu
through the standard UCLA
login id and password.
Dr. Kang Wang’s WIN-ing Formula
With a name bound for success, the Principle Investigators as well as representa-
Western Institute of Nanoelectronics, WIN tives from industry to make sure goals are
for short, is breaking ground by working in met.
the field of the very small. Thanks to the ef- Dr. Wang states that WIN con-
forts of WIN’s Director Dr. Kang Wang, an fronted the problem that “current compli-
engineering professor at UCLA since 1979, mentary metal oxide semiconductor (CMOS)
the lab maintains a unique focus on standards cannot function at a size any
nanoscience technology, specifically spin-
smaller than their current incarnation.”
tronics. Studying the innovations of spintronics and
WIN includes re- utilizing the energy pro-
searchers at UC Los Angeles, “We are talking about an duced by the spinning of
UC Berkeley, UC Santa Bar- unprecedented opportu- electrons can potentially
bara and Stanford along nity to help define a tech- lead to reducing both the
with 10 researchers from six power consumption and
industry sponsors who all nology that can exploit size of new technology. He
contribute to the develop- the idiosyncrasies of the also states that “with this
ment of spintronics. In addi- quantum world” new institute, we are talk-
tion to this manpower, WIN’s ing about an unprece-
funding source includes a dented opportunity to help
substantial commitment from those six in- define a technology that can exploit the idio-
dustry sponsors and a matching UC Discov- syncrasies of the quantum world to provide
ery Grant (http://ucdiscoverygrant.org/), key improvements over existing technolo-
which matches the company contribution. gies.”
As Director and an expert in the field The goal of WIN is to find a solution
of nanotechnology and semiconductors, to semiconductor size restrictions by 2020.
Wang serves as the liaison between the uni- Chief Operating Officer, Dr. Kos Galatsis
versity partners, working closely with other
See “Wang”, Continued on Page 4

Technology Transfer Internships for UCLA Students

Since 2005, the Office of Intellectual Property and Industry
Sponsored Research (OIP-ISR), has offered a paid summer intern-
ship program. OIP-ISR looks for interns with graduate student
backgrounds in the Life Sciences or Physical Sciences/Engineering,
or MBA students and Law students who are interested in learning
about commercializing technology and intellectual property, or to
supplement their science backgrounds with business and market-
ing experience.
Summer interns review invention disclosures, write non-
confidential summaries, and create company marketing lists
which are all used to help find potential industry licensees for fac-
ulty inventions. Interns also have the opportunity to shadow li-
censing officers during faculty inventor meetings and are offered
career development seminars. “This internship is an excellent idea
for graduate students, like myself, who want to move into the
business of science while still keeping ties to the cutting edge re-
search coming out of academia” says Melissa Moore, Ph.D. candi-
Interns for the Office of Intellectual Property: Brian Shedd, Amy
date for Molecular and Medical Pharmacology.
Hayden, Melissa Moore, and Pamela Douglas.
Students interested in applying for future summer intern-
ship positions, should start sending their completed applications (resume, mock non-confidential summary, and cover letter) to
OIP-ISR during the UCLA Winter quarter. There are also volunteer intern opportunities throughout the year. For more informa-
tion, visit the OIP-ISR website at www.research.ucla.edu/oipa/interns.
Volume 1, Issue 1

everything from marketing to licensing and has seen the of-

Meet the Staff– Emily Loughran
Director of Licensing for the Office of Intellectual Property
and Industry Sponsored Research
While completing an MBA at USC,
Emily Loughran’s unusual under-
grad background in science
caused a career counselor to sug-
gest that she pursue a job in tech-
nology transfer. That suggestion
lead to the City of Hope Hospital
where Emily began her work in
this new and relatively unknown
field. It was a major natural disaster
that brought Emily Loughran into
UCLA’s Technology Transfer Office. The now famous North-
ridge earthquake 14 years ago wreaked havoc on the south-
land and sent Emily looking for a new job.
Today, as the Director of Licensing, Emily oversees bringing an idea from inception to production.
fice go through major restructuring. Previously, each Technol-
ogy Transfer Officer (TTO) was responsible for managing
things “from the cradle to the grave.” Within the last eight
years, the specialization of different groups within the office
has created an environment that frees TTOs to spend more
time building relationships with faculty and industry while
focusing on their areas of expertise. As Emily attests, this
change has been “very beneficial and productive” for the of-
fice and the community it serves. Emily and her TTOs like to
work closely with each of their PIs. “The more involved the
faculty are in the marketing process, the better the outcome;
they are often the best source of marketing leads.”
From a (literally) shaky beginning, Emily has helped
to create a solid foundation within the office that allows and
even encourages a spirit of collaboration between officers
and faculty members. Emily’s focus and emphasis on faculty
involvement insures that faculty voices are being heard and
that dialogues can arise to help with the continued success of

Newly Issued UCLA Patents for 4th Quarter, FY2007-2008

Case Invention Title Inventors School Department Patent
No. No
2000-093 Synergism Between Proton Pump Inhibitors and Joseph R Pisegna MED MED 7,365,047
a GI Peptide in Reducing Acid Secretion
2001-194 Nucleotide Sequence Used In Preventive Ichiro Nishimura and DEN Den 7,365,175
Therapies for Wound Contraction and Fibrosis Cortino Sukotjo

2005-180 Lower Power Magnetic Random Access Memory Alexander Khitun and SEAS ELEC ENGR 7,366,011
Using the Effect of Hole-Mediated Kang L. Wang
Ferromagnetism
2004-328 Simox Fabrication Process Prakash Koonath and SEAS ELEC ENGR 7,368,359
Koichiro Kishima

2003-059 Compact Wavelength-Selective Optical Ming Chiang Wu SEAS ELEC ENGR 7,373,037
Crossconnect

2005-020 Method of Achieving Artificial Stability in Systems Alexander Khitun and SEAS ELEC ENGR 7,372,306
with Resonant Tunneling Diodes by Applying Kang L. Wang
Fast Excitations

2002-014 Closed-Loop Force Controlled Body Weight Susan J Harkema, Keith MED NEURO 7,381,163
Support System Gordon, Bjorn Svendesen, and
Sam El-Alami
2003-078 Cloning and Sequencing of Human Insulin Recep- William M Pardridge and MED MED-ENDO 7,388,079
tor Monoclonal Antibody Genes Ruben J. Boado

2003-201 Adaptive Multi-Bit Delta and Sigma-Delta Ali H. Sayed and SEAS ELEC ENGR 7,391,350
Modulation Mansoor A. Aldajani

2003-472 Zeroeth Order Resonator Tatsuo Itoh, Atsushi Sanada, SEAS ELEC ENGR 7,391,288
and Christophe Caloz
Volume 1, Issue 1

Open Source Software- Thinking About

Is There Such a Thing as a Free Lunch?
Open Source Software (OSS) is
software that does not charge a li-
cense fee to use it, and the source
code remains “open” or available to
use, change, improve, and redistribute
in a modified or unmodified form. The
low cost and availability of its code
separates OSS from Proprietary Soft-
ware (PS) which usually requires a li-
cense fee to acquire and restricts ac-
cess to source code. OSS can be a
practical choice for many software
applications. OSS is used at UCLA for
some applications including the cam-
pus course management system,
Moodle. There are many other applica-
tions running in different labs and
many students also use OSS. The pri-
mary advantage of OSS is cost, but at-
ready access to source code also al-
lows many developers to review and
improve the source code, potentially
producing more robust, less bug-
prone software.
While a free license may seem decisions about OSS products.
like a great deal, the use of OSS is not
always free. For example, OSS prod- Send your comments to Robin Faria at
ucts may have higher maintenance rfaria@conet.ucla.edu.
costs, service fees, or implementation
costs. Of greater concern to the uni-
versity are the provisions of some OSS
licenses that include statements about
liability and may reach into inventions
made at UCLA or other UC campuses.
These potential risks can generally be
managed through the careful review
of the copyright license.
Many people see the use of
OSS as a philosophical choice that is in
keeping with the University’s mission.
To that end, many faculty and stu-
dents have created their own OSS li-
censed products that they want to
release for public benefit. Care should
be used when releasing software and
in the selection of an OSS license since
you may be giving up rights that you
do not intend. UCLA’s Office of Infor-
mation Technology, Purchasing, and
the Office of Intellectual Property are
available to help you to review the
license and help faculty, administra-
tors, staff, and students make informed
Have an opinion on OSS?
Using OSS?
Points to Consider:
• Software is a form of intellectual prop-
erty and legal risks associated with
license violations are similar for both
Open Source Software and Proprie-
tary Software
• Speak with your IT Manager if you
would like to bring OSS into your de-
partment
• If you plan to use OSS within software
you are developing and you are being
sponsored by industry, OSS license
terms may conflict with terms of your
industry funding. Please contact your
Contracting Officer to make sure
there are no problematic terms and
conditions to the OSS license
• If using OSS as part of a program you
intend to license and sell, be aware of
whether a product’s license allows it
to be developed into and sold as part
of a proprietary product
• Contact the Copyright Officer, Kat
Fibiger, at kfibiger@research.ucla.edu
if you have questions or would like to
release or develop OSS

Things to Come... Wang, Continued

Coming soon to the Of-
fice of Intellectual Property (OIP)
website is an interactive way to
submit Incoming and Outgoing
Material Request Forms online.
Working with the Office of Re-
search Information Systems, OIP
has developed online request
forms that are accessible and
easy-to-use. These forms will help
the Material Transfer Agreement
officers facilitate the process for
PIs and expedite processing
through the office.
Once available online,
OIP will provide an educational
seminar for PIs and their staff.
Please continue to check
www.research.ucla.edu/oip for
the official launch of the online
submission forms.
states, “WIN’s spintronic based projects hold great promise in going beyond
CMOS”- a huge leap ahead in the realm of nanotechnologies.
WIN has the potential to propel semiconductor technology out of its
current limitations and into smaller, faster, and more efficient models. Because
of its multi-industry and multi-university conglomeration of talent and resources,
WIN is ready to become a major economic benefit to California, helping to es-
tablish the state as a premier location for nanoscale technologies. In addition,
following WIN’s example, other researchers can begin to look at the combina-
tion of industry funding and UC Discovery Grants as a viable source of capital
for future projects of any size.
Subscribe / Contact Us
11000 Kinross Blvd., Suite 200
Publisher: Kathryn A. Atchison
Los Angeles, CA 90095
Executive Editor: Robin Faria
www.research.ucla.edu/oip
Contributing Editor: Helen Liu
If you would like to be on the mailing list for
future newsletters, please email Robin Faria
Graphic Design: Ann Hu
at rfaria@conet.ucla.edu. With special thanks to: Bob Nidever

© 2008 UC Regents